http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 22 May 2026 16:08:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+667%2C+L.P./26541639.html si-local-file:///var/storage/secattach/20260522/26541639.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+667%2C+L.P./26541639.html Fri, 22 May 2026 16:08:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+667%2C+L.P./26541639.html si-local-file:///var/storage/secattach/20260522/26541639.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+667%2C+L.P./26541639.html Fri, 22 May 2026 16:08:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20/26541570.html si-local-file:///var/storage/secattach/20260522/26541570.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20/26541570.html Fri, 22 May 2026 16:07:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20/26541570.html si-local-file:///var/storage/secattach/20260522/26541570.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20/26541570.html Fri, 22 May 2026 16:07:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Klencke+Barbara/26541496.html si-local-file:///var/storage/secattach/20260522/26541496.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Klencke+Barbara/26541496.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Klencke+Barbara/26541496.html si-local-file:///var/storage/secattach/20260522/26541496.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Klencke+Barbara/26541496.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Dorton+Katina/26541505.html si-local-file:///var/storage/secattach/20260522/26541505.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Dorton+Katina/26541505.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Dorton+Katina/26541505.html si-local-file:///var/storage/secattach/20260522/26541505.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Dorton+Katina/26541505.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Gruia+Gabriela/26541525.html si-local-file:///var/storage/secattach/20260522/26541525.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Gruia+Gabriela/26541525.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Gruia+Gabriela/26541525.html si-local-file:///var/storage/secattach/20260522/26541525.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Gruia+Gabriela/26541525.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Woods+Keith/26541542.html si-local-file:///var/storage/secattach/20260522/26541542.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Woods+Keith/26541542.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Woods+Keith/26541542.html si-local-file:///var/storage/secattach/20260522/26541542.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Woods+Keith/26541542.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Nicholson+Garry+A/26541545.html si-local-file:///var/storage/secattach/20260522/26541545.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Nicholson+Garry+A/26541545.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Nicholson+Garry+A/26541545.html si-local-file:///var/storage/secattach/20260522/26541545.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+20++Filed+by%3A+Nicholson+Garry+A/26541545.html Fri, 22 May 2026 16:06:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++TScan+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+BIOTECHNOLOGY+VALUE+FUND+L+P/26505721.html si-local-file:///var/storage/secattach/20260515/26505721.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++TScan+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+BIOTECHNOLOGY+VALUE+FUND+L+P/26505721.html Fri, 15 May 2026 16:20:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++TScan+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+BIOTECHNOLOGY+VALUE+FUND+L+P/26505721.html si-local-file:///var/storage/secattach/20260515/26505721.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++TScan+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+BIOTECHNOLOGY+VALUE+FUND+L+P/26505721.html Fri, 15 May 2026 16:20:00 -0400 O.50995993 TCRX http://www.streetinsider.com/Earnings/TScan+Therapeutics%2C+Inc.+%28TCRX%29+Misses+Q1+EPS+by+4c/26446915.html <p>TScan Therapeutics, Inc. (NASDAQ: TCRX) reported Q1 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $1 million versus the consensus estimate of $2.5 million.</p><p>For earnings history and earnings-related data on TScan Therapeutics, Inc. (TCRX) <a href="http://www.streetinsider.com/ec_earnings.php?q=TCRX">click here</a>.</p> http://www.streetinsider.com/Earnings/TScan+Therapeutics%2C+Inc.+%28TCRX%29+Misses+Q1+EPS+by+4c/26446915.html Thu, 07 May 2026 06:00:24 -0400 TCRX http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++TScan+Therapeutics%2C+Inc.++For%3A+Mar+31/26439151.html si-local-file:///var/storage/secattach/20260506/26439151.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++TScan+Therapeutics%2C+Inc.++For%3A+Mar+31/26439151.html Wed, 06 May 2026 07:31:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++TScan+Therapeutics%2C+Inc.++For%3A+Mar+31/26439151.html si-local-file:///var/storage/secattach/20260506/26439151.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++TScan+Therapeutics%2C+Inc.++For%3A+Mar+31/26439151.html Wed, 06 May 2026 07:31:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+06/26439024.html si-local-file:///var/storage/secattach/20260506/26439024.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+06/26439024.html Wed, 06 May 2026 07:15:00 -0400 O.50995993 TCRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+06/26439024.html si-local-file:///var/storage/secattach/20260506/26439024.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++TScan+Therapeutics%2C+Inc.++For%3A+May+06/26439024.html Wed, 06 May 2026 07:15:00 -0400 O.50995993 TCRX http://www.streetinsider.com/Press+Releases/TScan+Therapeutics+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26438752.html <p align="center"><em>Early data on patients treated in Cohort C of the ALLOHA™ Phase 1 heme trial expected in the second quarter of 2026</em></p> <p align="center"><em>Initiation of Phase 3 study of TSC-101 (ALLOHA-2</em><em>™</em><em>) planned for the second quarter of 2026</em></p> <p align="center"><em>Initiation of Phase 1 study of TSC-102-A01 and TSC-102-A03 targeting CD45 in patients with HLA types A*01:01 and A*03:01 planned for the second half of 2026</em></p> <p align="center"><em>Cash and cash equivalents continue to fund operations into the second half of 2027 </em></p> <p align="justify">WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/TScan+Therapeutics+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26438752.html Wed, 06 May 2026 07:00:00 -0400 A.26566475 O.07320020 O.50995993 TCRX http://www.streetinsider.com/Press+Releases/TScan+Therapeutics+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26438752.html <p align="center"><em>Early data on patients treated in Cohort C of the ALLOHA™ Phase 1 heme trial expected in the second quarter of 2026</em></p> <p align="center"><em>Initiation of Phase 3 study of TSC-101 (ALLOHA-2</em><em>™</em><em>) planned for the second quarter of 2026</em></p> <p align="center"><em>Initiation of Phase 1 study of TSC-102-A01 and TSC-102-A03 targeting CD45 in patients with HLA types A*01:01 and A*03:01 planned for the second half of 2026</em></p> <p align="center"><em>Cash and cash equivalents continue to fund operations into the second half of 2027 </em></p> <p align="justify">WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/TScan+Therapeutics+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26438752.html Wed, 06 May 2026 07:00:00 -0400 A.26566475 O.07320020 O.50995993 TCRX http://www.streetinsider.com/Press+Releases/TScan+Therapeutics+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26438752.html <p align="center"><em>Early data on patients treated in Cohort C of the ALLOHA™ Phase 1 heme trial expected in the second quarter of 2026</em></p> <p align="center"><em>Initiation of Phase 3 study of TSC-101 (ALLOHA-2</em><em>™</em><em>) planned for the second quarter of 2026</em></p> <p align="center"><em>Initiation of Phase 1 study of TSC-102-A01 and TSC-102-A03 targeting CD45 in patients with HLA types A*01:01 and A*03:01 planned for the second half of 2026</em></p> <p align="center"><em>Cash and cash equivalents continue to fund operations into the second half of 2027 </em></p> <p align="justify">WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/TScan+Therapeutics+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26438752.html Wed, 06 May 2026 07:00:00 -0400 A.26566475 O.07320020 O.50995993 TCRX http://www.streetinsider.com/Press+Releases/TScan+Therapeutics+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26438752.html <p align="center"><em>Early data on patients treated in Cohort C of the ALLOHA™ Phase 1 heme trial expected in the second quarter of 2026</em></p> <p align="center"><em>Initiation of Phase 3 study of TSC-101 (ALLOHA-2</em><em>™</em><em>) planned for the second quarter of 2026</em></p> <p align="center"><em>Initiation of Phase 1 study of TSC-102-A01 and TSC-102-A03 targeting CD45 in patients with HLA types A*01:01 and A*03:01 planned for the second half of 2026</em></p> <p align="center"><em>Cash and cash equivalents continue to fund operations into the second half of 2027 </em></p> <p align="justify">WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. http://www.streetinsider.com/Press+Releases/TScan+Therapeutics+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26438752.html Wed, 06 May 2026 07:00:00 -0400 A.26566475 O.07320020 O.50995993 TCRX